Announcements Trials
Browse Landscape

Status

Recruiting 29Completed 28Unknown 24Terminated 6Active not recruiting 6Not yet recruiting 5Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Neoplasms 33Breast Neoplasms 32Lung Neoplasms 17Colorectal Neoplasms 16Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Hematologic Neoplasms 12Stomach Neoplasms 11Pancreatic Neoplasms 11Carcinoma, Hepatocellular 11Diabetes Mellitus 9Melanoma 7Disease 7Colonic Neoplasms 7Pulmonary Disease, Chronic Obstructive 6Cardiovascular Diseases 6Barrett Esophagus 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Liver Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pheochromocytoma 4Myasthenia Gravis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Lymphatic Metastasis 4Leiomyoma 4

Interventions

Focus Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Carcinoma, Transitional Cell × Clear all
NCT07454941 2026-03-06

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrolling by invitation
4,000 enrolled
Genitourinary

Carcinoma, Transitional Cell, Disease

NCT07091565 2025-08-03

SPARC

King's College London

Enrolling by invitation
60 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡